• All News
• 2021
• 2020
• 2019
• 2017
• 2016
• 2015
• 2014

Xenetic Biosciences, Inc. Reports First Quarter 2021 Financial Results

May 12, 2021

Xenetic Biosciences, Inc. to Present at the Q2 Virtual Investor Summit

May 10, 2021

Xenetic Biosciences, Inc. Receives Approval to Commence Exploratory Study of XCART(TM)

Mar 29, 2021

Xenetic Biosciences, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results

Mar 17, 2021

Xenetic Biosciences, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference

Mar 3, 2021

Xenetic Biosciences, Inc. Announces Partner's Filing of Registration Dossier in Russia for Epolong Product Candidate That Utilizes Xenetic's PolyXen(R) Platform Technology

Feb 16, 2021

Xenetic Biosciences, Inc. to Present at NobleCon17

Jan 14, 2021

Xenetic Biosciences, Inc. to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference

Jan 5, 2021

Xenetic Biosciences, Inc. Announces Closing of $6.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Dec 14, 2020

Xenetic Biosciences, Inc. Announces $6.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Dec 10, 2020

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• ...11
• Next »